Aireen® DR is medical device SW based on artificial intelligence. It provides non-invasive, pain-less screening of chronic diseases by analysing digital images of the retina. The retina is the only place in the human body where blood vessels can be seen by the naked eye. Artificial intelligence is cutting-edge breakthrough technology which allows for the precise identification of changes to the retina. It does so using the unique neural network models which Aireen® DR has created on the basis of:

• Over 1 million images which have been annotated in collaboration with leading retina specialists from prestigious eye clinics.



Since May 2023 Aireen® diabetic retinopathy screening has been certified as class IIb EU-MDR medical device.